Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Neuroinflammation with [11C]ER176
NCT03958630Phase 1Terminated
- Sponsor
- National Institute of Mental Health
- Start
- Jul 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [11C]ER176 (3 arms), sponsored by National Institute of Mental Health. Primary endpoint: Standard Uptake Value Ratio Area Under the Curve. Started Jul 2019; status: terminated.
02
Drugs
[11C]ER176
Beyond the preview
Go deeper on NCT03958630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03958630.